Extrawell Pharmaceutical Holdings Ltd. Stock: price and insider trades · Hong Kong
5 insiders bought shares over the last 90 days, the latest by WONG SAU KUEN, filed 26 Oct 2026.
Cluster: 3 buyers in 30 daysExtrawell Pharmaceutical Holdings Ltd.: what insiders have been doing
This page follows insider dealings at Extrawell Pharmaceutical Holdings Ltd. as filed with HKEX, a company from the Health Care sector. Over the twelve months to 26 October 2026, 13 filings were filed, from 6 insiders.
The record shows 11 purchases on the open market worth €5,806, made by 6 insiders, against 2 sales by 1 insider. The totals do not cover 11 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. At €4,722, the purchase published on 18 December 2025 by CHENG Yong is the largest of the period. On the buying side, the filings list 6 senior executives among the declarants.
With 13 filings in twelve months, the company is more active than the median of 4 filings across the 1,315 companies we follow on the same exchange. Over the whole record (from 2019), the tally stands at 12 purchases and 4 sales.
The latest purchase is recent: it was published 13 days ago, on 26 October 2026. Between a trade and the moment it shows up on HKEX, the median delay is 5 days. That lag is the time during which only the insider knows about the trade.
In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. Source: insider filings from HKEX. Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- -46.7%Entry HK$0.09 · Close 23 Oct 2026 HK$0.05
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended March 2025 · cache
- 23,000,000 sharesShareXHKGHKEX:DA20261023E00611Canonical exit: 19 Jan 2027 (T+90)
- 23,000,000 sharesShareXHKGHKEX:DA20261023E00499Canonical exit: 19 Jan 2027 (T+90)
- 23,000,000 sharesShareXHKGHKEX:DA20261022E00466Canonical exit: 19 Jan 2027 (T+90)
- 350,000,000 sharesShareXHKGHKEX:DA20260917E00400
- 70,000,000 sharesShareXHKGHKEX:DA20260907E00494Canonical exit: 2 Dec 2026 (T+90)
- 50,000,000 sharesShareXHKGHKEX:DA20260904E00528Canonical exit: 2 Dec 2026 (T+90)
- 350,000,000 sharesShareXHKGHKEX:DA20260814E00531Canonical exit: 9 Nov 2026 (T+90)
- 550,000,000 sharesShareXHKGHKEX:DA20260814E00526Canonical exit: 9 Nov 2026 (T+90)
- 900,000,000 sharesShareXHKGHKEX:DA20251227E00001
- 25,500,000 sharesShareXHKGHKEX:DA20251224E00022Canonical exit: 19 Mar 2026 (T+90)
- 25,500,000 sharesShareXHKGHKEX:DA20251223E00230Canonical exit: 19 Mar 2026 (T+90)
- 480,000 shares@ HK$0.0981.3% of flowShareXHKGHKEX:DA20251218E00492Canonical exit: 16 Mar 2026 (T+90)
- 110,000 shares@ HK$0.0918.7% of flowShareXHKGHKEX:DA20251218E00041Canonical exit: 15 Mar 2026 (T+90)
- 0ShareXHKGHKEX:DA20250912E00025
- 900,000,000 sharesShareXHKGHKEX:DA20250911E00436
- 139,700,000 sharesShareXHKGHKEX:DA20250710E00601
- 900,000,000 sharesShareXHKGHKEX:DA20191227E00251Canonical exit: 22 Mar 2020 (T+90)
- 80,000,000 shares@ HK$0.091100.0% of flowShareXHKGHKEX:DA20190805E00209
18 of 18 declarations
About Extrawell Pharmaceutical Holdings Ltd.
Extrawell Pharmaceutical Holdings Ltd. is a company focused on the development and manufacturing of pharmaceutical products. It emphasizes innovation in the healthcare sector and offers a range of medications and treatments.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
